Thomas Lynch
Net worth: 52 924 $ as of 2026-07-30
Net worth: 52 924 $ as of 2026-07-30
Thomas W.
Lynch is currently Director at Bioforward, Inc. and Chief Business Officer at MindWalk Holdings Corp.
Starting in 2025, the role at MindWalk Holdings Corp.
began.
Formerly, Dr. Lynch was Vice President-Global Sales & Client Services at Aldevron LLC.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-07-21 | 41,026 ( 0.09% ) | 52 924 $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| MINDWALK HOLDINGS CORP. | Corporate Officer/Principal | 2025-10-19 |
Bioforward, Inc.
Bioforward, Inc. Investment ManagersFinance Alternative investment manager | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Manufactures and develops biological science products | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 3 |
|---|---|
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Manufactures and develops biological science products | Health Technology |
Bioforward, Inc.
Bioforward, Inc. Investment ManagersFinance Alternative investment manager | Finance |
ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd. BiotechnologyHealth Technology Operates as AI-driven biotherapeutic research and technology firm that develops & discovers antibodies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions